INTRODUCTION: This study was aimed to assess clinical safety and efficacy of the LVIS Jr. microstent in stent-assisted coil embolization of wide-neck intracranial aneurysms. METHODS: IRB approved single-center interventional clinical study in 22 patients (10 females, 12 males, mean age 55, age range 33-74 years) for the endovascular treatment of wide-neck aneurysms. After obtaining informed consent, patients were included according to the following criteria: aneurysm fundus-to-neck ratio < 2 or neck diameter > 4 mm, and a parent vessel diameter of ≤3.5 mm. Primary end point for clinical safety was absence of death, absence of major or minor stroke, and absence of transient ischemic attack. Primary end point for treatment efficacy was complete angiographic occlusion according to the Raymond-Roy Occlusion Classification (RROC) immediately after the procedure and at follow-up after 3 and 6 months on magnetic resonance imaging (MRI). RESULTS: In 20/22 (91 %) of patients, the primary end point of safety was reached; in the two remaining patients, transient ischemic attack, but no permanent deficit was observed; in 16/22 (73 %), efficient occlusion (RROC1) was reached, and in 6/22 (27 %), a residual neck remained (RROC2). Single [seven with antegrade, two in crossover configuration, and four with "first-balloon-then-stent" (FBTS) technique] or double-stent (eight patients with Y configuration and one patient with X configuration) deployment was technically successful in all cases. CONCLUSION: Deployment of the LVIS Jr. microstent in various single- or double-stent configurations is safe and effective to assist the treatment of intracranial wide-neck aneurysms.
INTRODUCTION: This study was aimed to assess clinical safety and efficacy of the LVIS Jr. microstent in stent-assisted coil embolization of wide-neck intracranial aneurysms. METHODS: IRB approved single-center interventional clinical study in 22 patients (10 females, 12 males, mean age 55, age range 33-74 years) for the endovascular treatment of wide-neck aneurysms. After obtaining informed consent, patients were included according to the following criteria: aneurysm fundus-to-neck ratio < 2 or neck diameter > 4 mm, and a parent vessel diameter of ≤3.5 mm. Primary end point for clinical safety was absence of death, absence of major or minor stroke, and absence of transient ischemic attack. Primary end point for treatment efficacy was complete angiographic occlusion according to the Raymond-Roy Occlusion Classification (RROC) immediately after the procedure and at follow-up after 3 and 6 months on magnetic resonance imaging (MRI). RESULTS: In 20/22 (91 %) of patients, the primary end point of safety was reached; in the two remaining patients, transient ischemic attack, but no permanent deficit was observed; in 16/22 (73 %), efficient occlusion (RROC1) was reached, and in 6/22 (27 %), a residual neck remained (RROC2). Single [seven with antegrade, two in crossover configuration, and four with "first-balloon-then-stent" (FBTS) technique] or double-stent (eight patients with Y configuration and one patient with X configuration) deployment was technically successful in all cases. CONCLUSION: Deployment of the LVIS Jr. microstent in various single- or double-stent configurations is safe and effective to assist the treatment of intracranial wide-neck aneurysms.
Authors: Charles B L M Majoie; Marieke E Sprengers; Willem Jan J van Rooij; Cristina Lavini; Menno Sluzewski; Jeroen C van Rijn; Gerard J den Heeten Journal: AJNR Am J Neuroradiol Date: 2005 Jun-Jul Impact factor: 3.825
Authors: Werner Weber; Martin Bendszus; Bernhard Kis; Thierry Boulanger; László Solymosi; Dietmar Kühne Journal: Neuroradiology Date: 2007-05-03 Impact factor: 2.804
Authors: Alessandra Biondi; Vallabh Janardhan; Jeffrey M Katz; Kimberly Salvaggio; Howard A Riina; Y Pierre Gobin Journal: Neurosurgery Date: 2007-09 Impact factor: 4.654
Authors: Alejandro M Spiotta; Amrendra Miranpuri; M Imran Chaudry; Raymond D Turner; Aquilla S Turk Journal: J Neurointerv Surg Date: 2012-11-20 Impact factor: 5.836
Authors: P Machi; V Costalat; K Lobotesis; C Ruiz; Y B Cheikh; O Eker; G Gascou; F Danière; C Riquelme; A Bonafé Journal: AJNR Am J Neuroradiol Date: 2015-08-13 Impact factor: 3.825
Authors: Markus A Möhlenbruch; Johannes Pfaff; Christian Herweh; Julian Bösel; Timolaos Rizos; Simon Nagel; Peter A Ringleb; Martin Bendszus; Mirko Pham Journal: Neuroradiology Date: 2016-06-16 Impact factor: 2.804
Authors: I Akmangit; K Aydin; S Sencer; O M Topcuoglu; E D Topcuoglu; E Daglioglu; M Barburoglu; A Arat Journal: AJNR Am J Neuroradiol Date: 2014-09-18 Impact factor: 3.825
Authors: N Takano; M Suzuki; R Irie; M Yamamoto; K Teranishi; K Yatomi; N Hamasaki; K K Kumamaru; M Hori; H Oishi; S Aoki Journal: AJNR Am J Neuroradiol Date: 2017-05-18 Impact factor: 3.825